133 related articles for article (PubMed ID: 16824707)
21. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
Cheboyina S; Wyandt CM
Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
[TBL] [Abstract][Full Text] [Related]
22. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
[TBL] [Abstract][Full Text] [Related]
23. Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.
Punyamurthula NS; Hingorani T; Adelli G; Gul W; ElSohly MA; Repka MA; Majumdar S
Drug Dev Ind Pharm; 2016; 42(7):1158-64. PubMed ID: 26585693
[TBL] [Abstract][Full Text] [Related]
24. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
[TBL] [Abstract][Full Text] [Related]
25. Sustained delivery of captopril from floating matrix tablets.
Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
[TBL] [Abstract][Full Text] [Related]
26. Floating pellets containing bacterial antagonist for control sheath blight of rice: formulations, viability and bacterial release studies.
Wiwattanapatapee R; Pengnoo A; Kanjanamaneesathian M; Matchavanich W; Nilratana L; Jantharangsri A
J Control Release; 2004 Mar; 95(3):455-62. PubMed ID: 15023457
[TBL] [Abstract][Full Text] [Related]
27. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
28. Alcohol dose dumping: The influence of ethanol on hot-melt extruded pellets comprising solid lipids.
Jedinger N; Schrank S; Mohr S; Feichtinger A; Khinast J; Roblegg E
Eur J Pharm Biopharm; 2015 May; 92():83-95. PubMed ID: 25733499
[TBL] [Abstract][Full Text] [Related]
29. Formulation and evaluation of sustained release floating capsules of nicardipine hydrochloride.
Moursy NM; Afifi NN; Ghorab DM; El-Saharty Y
Pharmazie; 2003 Jan; 58(1):38-43. PubMed ID: 12622251
[TBL] [Abstract][Full Text] [Related]
30. Development and optimization of multiparticulate drug delivery system of alfuzosin hydrochloride.
Pagariya TP; Patil SB
Colloids Surf B Biointerfaces; 2013 Feb; 102():171-7. PubMed ID: 23010113
[TBL] [Abstract][Full Text] [Related]
31. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
32. A floating multiparticulate system for ofloxacin based on a multilayer structure: In vitro and in vivo evaluation.
Zhang C; Xu M; Tao X; Tang J; Liu Z; Zhang Y; Lin X; He H; Tang X
Int J Pharm; 2012 Jul; 430(1-2):141-50. PubMed ID: 22525085
[TBL] [Abstract][Full Text] [Related]
33. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets.
Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L
Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036
[TBL] [Abstract][Full Text] [Related]
34. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter pylori.
Patel SS; Ray S; Thakur RS
Acta Pol Pharm; 2006; 63(1):53-61. PubMed ID: 17515330
[TBL] [Abstract][Full Text] [Related]
35. Influence of melting and rheological properties of fatty binders on the melt granulation process in a high-shear mixer.
Evrard B; Amighi K; Beten D; Delattre L; Moës AJ
Drug Dev Ind Pharm; 1999 Nov; 25(11):1177-84. PubMed ID: 10596355
[TBL] [Abstract][Full Text] [Related]
36. Technology of stable, prolonged-release eye-drops containing Cyclosporine A, distributed between lipid matrix and surface of the solid lipid microspheres (SLM).
Wolska E; Sznitowska M
Int J Pharm; 2013 Jan; 441(1-2):449-57. PubMed ID: 23164704
[TBL] [Abstract][Full Text] [Related]
37. A dual strategy to improve psychotic patients' compliance using sustained release quetiapine oral disintegrating tablets.
Refaat A; Sokar M; Ismail F; Boraei N
Acta Pharm; 2016 Dec; 66(4):515-532. PubMed ID: 27749256
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of new sustained-release floating microspheres.
Ma N; Xu L; Wang Q; Zhang X; Zhang W; Li Y; Jin L; Li S
Int J Pharm; 2008 Jun; 358(1-2):82-90. PubMed ID: 18407442
[TBL] [Abstract][Full Text] [Related]
39. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline].
Laicher A; Fuchs WS
Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341
[TBL] [Abstract][Full Text] [Related]
40. A novel floating controlled release drug delivery system prepared by hot-melt extrusion.
Vo AQ; Feng X; Morott JT; Pimparade MB; Tiwari RV; Zhang F; Repka MA
Eur J Pharm Biopharm; 2016 Jan; 98():108-21. PubMed ID: 26643801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
